3 | SEC Filings Hub

Filing metadata

Accession number: 0001213900-24-011795
Form type: Form 3
Filer: BridgeBio Oncology Therapeutics, Inc.
CIK: CIK 1869105
Filed: Feb 09, 2024
Reporting period: Feb 08, 2024
Description: Initial ownership

Documents

0001213900-24-011795-index.htm

Complete submission

0001213900-24-011795.txt

directory listing

Filed by

BridgeBio Oncology Therapeutics, Inc.